TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA ...
Babies born in the U.S. between July 2 and Dec. 31, 2026, will receive a "first-of-its-kind" commemorative Social Security card.
Nyra Medical, Inc., a clinical-stage medical technology company developing a novel transcatheter solution for functional ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
Discover how exercise activates a molecular switch to reduce DEAF1 levels, restoring muscle health and function in older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results